Question 1

What are the potential side effects of ruxolitinib phosphate cream?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) clinical trial (NCT02553330). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for alopecia areata?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) clinical trial (NCT02553330). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the application process for the cream involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) clinical trial (NCT02553330). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) clinical trial (NCT02553330). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) clinical trial (NCT02553330). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel requirements for attending study visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) clinical trial (NCT02553330). Contact the study team or your healthcare provider for specific answers.

What this study is about